Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 567

Similar articles for PubMed (Select 15363860)

1.

RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis.

Wittrant Y, Théoleyre S, Chipoy C, Padrines M, Blanchard F, Heymann D, Rédini F.

Biochim Biophys Acta. 2004 Sep 20;1704(2):49-57. Review.

PMID:
15363860
2.

The "Mechanostat Theory" of Frost and the OPG/RANKL/RANK System.

Tyrovola JB.

J Cell Biochem. 2015 Jun 20. doi: 10.1002/jcb.25265. [Epub ahead of print]

PMID:
26096594
3.

Immunology of Osteoporosis: A Mini-Review.

Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Föger-Samwald U, Ellinger I.

Gerontology. 2015 Jun 17. [Epub ahead of print]

PMID:
26088283
4.

The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.

Zhang L, Teng Y, Fan Y, Wang Y, Li W, Shi J, Ma Y, Li C, Shi X, Qu X, Liu Y.

Oncotarget. 2015 Jun 8. [Epub ahead of print]

5.

Biomarkers of vascular calcifications: the osteoprotegerin/RANK/RANK L axis.

Bargnoux AS, Morena M, Arnaud J, Cavalier É, Zaoui P, Delanaye P, Cristol JP, de Travail Mixte Sfbc/Sn Biomarqueurs des Calcifications Vasculaires Au Cours de L'insuffisance Rénale Chronique G.

Ann Biol Clin (Paris). 2015 Jun 1;73(3):289-298.

PMID:
26069065
6.

Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss.

Crotti TN, Dharmapatni AA, Alias E, Haynes DR.

J Immunol Res. 2015;2015:281287. Epub 2015 May 3. Review.

7.

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

Szwarc MM, Kommagani R, Jacob AP, Dougall WC, Ittmann MM, Lydon JP.

PLoS One. 2015 Jun 10;10(6):e0128467. doi: 10.1371/journal.pone.0128467. eCollection 2015.

8.

Osteoprotegerin in breast cancer: beyond bone remodeling.

Weichhaus M, Chung ST, Connelly L.

Mol Cancer. 2015 Jun 10;14:117. doi: 10.1186/s12943-015-0390-5.

9.

Generalized Degenerative Joint Disease in Osteoprotegerin (Opg) Null Mutant Mice.

Bolon B, Grisanti M, Villasenor K, Morony S, Feige U, Simonet WS.

Vet Pathol. 2015 May 27. pii: 0300985815586221. [Epub ahead of print]

PMID:
26018435
10.

The multiple myeloma bone eco-system and its relation to oncogenesis.

Bataille R.

Morphologie. 2015 Jun;99(325):31-7. doi: 10.1016/j.morpho.2015.03.002. Epub 2015 May 23.

PMID:
26005000
11.

B Cell Production of Both OPG and RANKL is Significantly Increased in Aged Mice.

Li Y, Terauchi M, Vikulina T, Roser-Page S, Weitzmann MN.

Open Bone J. 2014;6:8-17.

12.

Improved efficacy of soluble human receptor activator of nuclear factor kappa B (RANK) fusion protein by site-directed mutagenesis.

Son YJ, Han J, Lee JY, Kim H, Chun T.

Immunopharmacol Immunotoxicol. 2015 Jun;37(3):221-7. doi: 10.3109/08923973.2015.1035392. Epub 2015 May 14.

PMID:
25974308
13.

OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism.

Ardeshirpour L, Dumitru C, Dann P, Sterpka J, VanHouten J, Kim W, Kostenuik P, Wysolmerski J.

Endocrinology. 2015 May 11:en20151232. [Epub ahead of print]

PMID:
25961842
14.

Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.

Armada L, Santos Marotta PD, Pires FR, Siqueira JF Jr.

J Endod. 2015 May 5. pii: S0099-2399(15)00307-6. doi: 10.1016/j.joen.2015.03.025. [Epub ahead of print]

PMID:
25956608
15.
16.

Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor (NF)-Kappa B (RANK) Signaling.

Golden D, Saria EA, Hansen MF.

J Cell Physiol. 2015 Apr 20. doi: 10.1002/jcp.25024. [Epub ahead of print]

PMID:
25893522
17.

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer.

Msaouel P, Galeas JN, Boiles AR, Ruiz RR, Koutsilieris M.

Curr Drug Targets. 2015 Apr 20. [Epub ahead of print]

PMID:
25892311
18.

Correlating RANK Ligand/RANK Binding Kinetics with Osteoclast Formation and Function.

Warren JT, Zou W, Decker CE, Rohatgi N, Nelson CA, Fremont DH, Teitelbaum SL.

J Cell Biochem. 2015 Apr 10. doi: 10.1002/jcb.25191. [Epub ahead of print]

PMID:
25864714
19.

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.

Azim HA Jr, Peccatori FA, Brohée S, Branstetter D, Loi S, Viale G, Piccart M, Dougall WC, Pruneri G, Sotiriou C.

Breast Cancer Res. 2015 Feb 21;17:24. doi: 10.1186/s13058-015-0538-7.

20.

IL-10 critically modulates B cell responsiveness in Rankl-/- mice.

Marrella V, Lo Iacono N, Fontana E, Sobacchi C, Sic H, Schena F, Sereni L, Castiello MC, Poliani PL, Vezzoni P, Cassani B, Traggiai E, Villa A.

J Immunol. 2015 May 1;194(9):4144-53. doi: 10.4049/jimmunol.1401977. Epub 2015 Mar 30.

PMID:
25825446
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk